A review on drug-diet interaction

• Authors: Waheed Sakariyau Adio , Adeola Christiana Ogunwole , Folorunso Ibikun Mary
• Languages of publication: EN

Abstracts

EN

Food-drug interactions can have a significant impact on the efficacy of pharmacological treatment and the adverse effect profiles of many treatments. Interactions are not necessarily harmful to therapy, but they can be employed to promote drug absorption or reduce side effects in some circumstances. Drug interactions with grapefruit juice, in particular, have gotten a lot of attention recently. As new drugs are approved at a faster rate, there is less information accessible concerning their side effects and interactions once they hit the market. The use of herbal medicines and dietary supplements is a second source of worry. These items are not subjected to rigorous testing and may contain little or no of the ingredient listed on the label. Some of the herbs utilized have the potential to interact negatively with prescription medications. Mahuang (ephedra) and fever few are two noteworthy examples. Mahuang is a stimulant that can lead to hypertension in those who are on monoamine oxidase inhibitors. Fever fever has anticoagulant qualities that can help warfarin work better. The majority of food-drug interactions occur due to one of three mechanisms: decreased absorption rate or extent, enhanced absorption rate or extent, or chemical/pharmacologic effects. Acid-labile medicines, such as penicillin G, ampicillin, and dicloxacillin, are destroyed when there is an increase in stomach acid. In other circumstances, dietary components like calcium or iron may create compounds with the medicine that make it harder to absorb. Tetracycline, sodium fluoride, and ciprofloxacin are some examples. Food, calcium, and practically everything, including orange juice and coffee, interfere with lendronate absorption. The exact process through which food interferes with absorption is unknown in many circumstances. The area under the curve (AUC) may be comparable regardless of how the drug is administered; delayed absorption does not always diminish total overall exposure to the drug.

Keywords

EN

Diet; Drugs; Interaction; pharmaceuticals

Discipline

• FOOD_&_NUTRITION: FOOD & NUTRITION

• Publisher: Scientific Publishing House „DARWIN”
• Journal: World News of Natural Sciences
• Year: 2022
• Volume: 43
• Pages: 108-125

Contributors

author

Waheed Sakariyau Adio

• Department of Biochemistry, Faculty of Life Science, Federal University of Technology Minna, Bosso LGA, Niger State, Nigeria

author

Adeola Christiana Ogunwole

• Department of Biochemistry, Faculty of Life Science, Federal University of Technology Minna, Bosso LGA, Niger State, Nigeria

author

Folorunso Ibikun Mary

• Federal University of Technology, Akure, Ondo State, Nigeria

References

• [1] Paine, M. F., & Oberlies, N. H. (2007). Clinical relevance of the small intestine as an organ of drug elimination: drug–fruit juice interactions. Expert Opinion on Drug Metabolism & Toxicology, 3(1), 67-80
• [2] Kaur, G., & Buttar, H. S. (2016). Potential Adverse Interactions Between Allopathic Drugs, Herbals and Dietary Products: Mechanisms of Action and Clinical Implications. J Diabetes Metab Disord, 3 (009). DOI: 10.24966/DMD-201X/100009
• [3] Park, J. E., Kim, H. S., Chang, M. J., & Hong, H. S. (2014). Implementation of ontology-based clinical decision support system for management of interactions between antihypertensive drugs and diet. Journal of Korean Academy of Nursing, 44(3), 294-304
• [4] Thiele, I., Clancy, C. M., Heinken, A., & Fleming, R. M. (2017). Quantitative systems pharmacology and the personalized drug–microbiota–diet axis. Current Opinion in Systems Biology, 4, 43-52
• [5] Sørensen, J. M. (2002). Herb–drug, food–drug, nutrient–drug, and drug–drug interactions: mechanisms involved and their medical implications. The Journal of Alternative & Complementary Medicine, 8(3), 293-308
• [6] Chan, J., Oshiro, T., Thomas, S., Higa, A., Black, S., Todorovic, A., ... & Harrelson, J. P. (2016). Inactivation of CYP2A6 by the dietary phenylpropanoid trans-cinnamic aldehyde (cinnamaldehyde) and estimation of interactions with nicotine and letrozole. Drug Metabolism and Disposition, 44(4), 534-543
• [7] Wright, J. A., Haslam, I. S., Coleman, T., & Simmons, N. L. (2011). Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers. European Journal of Pharmacology, 672(1-3), 70-76
• [8] VanderMolen, K. M. (2014). Quantitative analysis of grapefruit constituents involved in diet-drug interactions and modification of the microbial metabolome. The University of North Carolina at Greensboro.
• [9] Woolf, E. C., & Scheck, A. C. (2015). The ketogenic diet for the treatment of malignant glioma. Journal of Lipid Research, 56(1), 5-10
• [10] Green, C. L., & Lamming, D. W. (2021). A food with medicine approach to health. Cell Metabolism, 33(12), 2303-2304
• [11] Krieger, J. P., Langhans, W., & Lee, S. J. (2018). Novel role of GLP-1 receptor signaling in energy expenditure during chronic high fat diet feeding in rats. Physiology & Behavior, 192, 194-199
• [12] Ma, K., Hu, Y., & Smith, D. E. (2012). Influence of fed-fasted state on intestinal PEPT1 expression and in vivo pharmacokinetics of glycylsarcosine in wild-type and Pept1 knockout mice. Pharmaceutical Research, 29(2), 535-545
• [13] Fanelli, A. (2015). Regional versus generalanesthesia and postoperative venous thromboembolism. Decision-Making in Orthopedic and Regional Anesthesiology: A Case-Based Approach, 123.
• [14] Rogers, A. S. (1994). The role of cytochrome P450 in developmental pharmacology. Journal of Adolescent Health, 15(8), 635-640
• [15] Roma, M. I., Lampropulos, V. E. S., Ayllón-Cabrera, I., Sanabria, A. N. S., Nigro, M. M. L., Peroni, R. N., & Carballo, M. A. (2019). Modulation of hepatic ABC transporters by Eruca vesicaria intake: Potential diet-drug interactions. Food and Chemical Toxicology, 133, 110797
• [16] Amadi, C. N., & Aghalibe, P. O. (2019). Evaluation of Drug-diet interaction between Psidium guajava (Guava) fruit and Metoclopramide. Journal of Drug Delivery and Therapeutics, 9(2), 144-147
• [17] Dello Russo, C., Bandiera, T., Monici, M., Surdo, L., Yip, V. L. M., Wotring, V., & Morbidelli, L. (2022). Physiological adaptations affecting drug pharmacokinetics in space: what do we really know? A critical review of the literature. British Journal of Pharmacology Volume 179, Issue 11, Pages 2538-2557
• [18] Harper, K. M., Knapp, D. J., Park, M. A., & Breese, G. R. (2018). Differential effects of single versus repeated minocycline administration—Lack of significant interaction with chronic alcohol history. Pharmacology Biochemistry and Behavior, 168, 33-42
• [19] Shelton, H. W. (2019). The Effects of Two Novel Anti-Inflammatory Compounds on Prepulse Inhibition and Neural Microglia Cell Activation in a Rodent Model of Schizophrenia (Doctoral dissertation, East Tennessee State University).
• [20] Lee, S. H., Kim, H. Y., Back, S. Y., & Han, H. K. (2018). Piperine-mediated drug interactions and formulation strategy for piperine: Recent advances and future perspectives. Expert Opinion on Drug Metabolism & Toxicology, 14(1), 43-57
• [21] Norvaisas, P. (2019). Interaction between host, microbiota, diet and drugs in C. elegans and E. coli (Doctoral dissertation, UCL (University College London)).
• [22] van de Kerkhof, E. G., de Graaf, I. A., de Jager, M. H., Meijer, D. K., & Groothuis, G. M. (2005). Characterization of rat small intestinal and colon precision-cut slices as an in vitro system for drug metabolism and induction studies. Drug Metabolism and Fisposition, 33(11), 1613-1620
• [23] Li, M., Chen, P. Z., Yue, Q. X., Li, J. Q., Chu, R. A., Zhang, W., & Wang, H. (2013). Pungent ginger components modulates human cytochrome P450 enzymes in vitro. Acta Pharmacologica Sinica, 34(9), 1237-1242
• [24] Chandler-Laney, P. C., Castaneda, E., Pritchett, C. E., Smith, M. L., Giddings, M., Artiga, A. I., & Boggiano, M. M. (2007). A history of caloric restriction induces neurochemical and behavioral changes in rats consistent with models of depression. Pharmacology Biochemistry and Behavior, 87(1), 104-114
• [25] Jensen, K., Ni, Y., Panagiotou, G., & Kouskoumvekaki, I. (2015). Developing a molecular roadmap of drug-food interactions. PLOS Computational Biology, 11(2), e1004048
• [26] Karadima, V., Kraniotou, C., Bellos, G., & Tsangaris, G. T. (2016). Drug-micronutrient interactions: food for thought and thought for action. EPMA Journal, 7(1), 1-5
• [27] Dorneles, I. M. P., Fucks, M. B., Fontela, P. C., Frizzo, M. N., & Winkelmann, E. R. (2018). Guarana (Paullinia cupana) presents a safe and effective anti-fatigue profile in patients with chronic kidney disease: A randomized, double-blind, three-arm, controlled clinical trial. Journal of Functional Foods, 51, 1-7
• [28] Jewett, D. C., Liyanagamage, D. S., Avond, M. A. V., Anderson, M. A., Twaroski, K. A., Marek, M. A., ... & Levine, A. S. (2022). Chronic Intermittent Sucrose Consumption Facilitates the Ability to Discriminate Opioid Receptor Blockade with Naltrexone in Rats. Nutrients, 14(5), 926
• [29] Hyndman, K. A., Isaeva, E., Palygin, O., Mendoza, L. D., Rodan, A. R., Staruschenko, A., & Pollock, J. S. (2021). Role of collecting duct principal cell NOS1β in sodium and potassium homeostasis. Physiological Reports, 9(20), e15080
• [30] Maas, R., & Böger, R. H. (2003). Antihypertensive therapy: special focus on drug interactions. Expert Opinion on Drug Safety, 2(6), 549-579
• [31] Asif, M. (2011). The role of fruits, vegetables, and spices in diabetes. International Journal of Nutrition, Pharmacology, Neurological Diseases, 1(1), 27
• [32] Barros, E. (2011). Interaction of traditional remedies against HIV, nutrients and ARVs. Recent Translational Research in HIV/AIDS, 1, 111-126
• [33] Kinsella, L. J., Grossberg, G. T., & Prakash, N. (2018). Drug-Dietary Interactions: Over-the-Counter Medications, Herbs, and Dietary Supplements. In Clinical Psychopharmacology for Neurologists (pp. 213-224). Springer, Cham.
• [34] Abuyassin, B., & Laher, I. (2015). Obesity-linked diabetes in the Arab world: a review. East Mediterr Health J, 21(6), 420-39
• [35] Deitelzweig, S. B., Buysman, E., Pinsky, B., Lacey, M., Jing, Y., Wiederkehr, D., & Graham, J. (2013). Warfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care population. Clinical Therapeutics, 35(8), 1201-1210
• [36] Jiang, Y., Jin, M., Chen, J., Yan, J., Liu, P., Yao, M., ... & Pi, R. (2020). Discovery of a novel niacin-lipoic acid dimer N2L attenuating atherosclerosis and dyslipidemia with non-flushing effects. European Journal of Pharmacology, 868, 172871
• [37] Daykin, N., Orme, J., Evans, D., Salmon, D., McEachran, M., & Brain, S. (2008). The impact of participation in performing arts on adolescent health and behaviour: a systematic review of the literature. Journal of Health Psychology, 13(2), 251-264
• [38] Kaur, G., & Buttar, H. S. (2016). Potential Adverse Interactions Between Allopathic Drugs, Herbals and Dietary Products: Mechanisms of Action and Clinical Implications. J Diabetes Metab Disord, 3(009)
• [39] Komperda, K. E. (2009). Potential interaction between pomegranate juice and warfarin. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 29(8), 1002-1006
• [40] Mahmoud, A. M. (2012). Influence of rutin on biochemical alterations in hyperammonemia in rats. Experimental and Toxicologic Pathology, 64(7-8), 783-789.
• [41] Smith, E. C. (2017). Effects of the Antihistamine Fexofenadine on Body Fat, Glucose and Body Weight: Impact of Dietary Fat Type and Pre-Drug Run-in Period. Indiana University of Pennsylvania.
• [42] Li, M., Wang, B., Zhang, M., Rantalainen, M., Wang, S., Zhou, H., ... & Zhao, L. (2008). Symbiotic gut microbes modulate human metabolic phenotypes. Proceedings of the National Academy of Sciences, 105(6), 2117-2122.
• [43] Terrill, K. R., Wheeler, M., Rollins, D. E., & Beckwith, M. C. (2000). Drug Interactions Reported with Grapefruit Juice. Journal of Pharmaceutical Care in Pain & Symptom Control, 8(3), 39-48
• [44] Jefferson, J. W. (1998). Drug and diet interactions: avoiding therapeutic paralysis. Journal of Clinical Psychiatry, 59(16), 31-39
• [45] Pillsbury, L., Miller, E. A., Boon, C., & Pray, L. (Eds.). (2010). Providing Healthy and Safe Foods As We Age: Workshop Summary. National Academies Press.
• [46] Bied, A. M., Kim, J., & Schwartz, T. L. (2015). A critical appraisal of the selegiline transdermal system for major depressive disorder. Expert Review of Clinical Pharmacology, 8(6), 673-681
• [47] Hornung, M., Franke, J., & Sievert, H. (2015). Left Atrial Appendage Occlusion for Preventing Stroke—Step-by-Step Technique and Current Status. Handbook of Interventions for Structural Heart and Peripheral Vascular Disease, 78.
• [48] Widmer, N., Bardin, C., Chatelut, E., Paci, A., Beijnen, J., Levêque, D., ... & Astier, A. (2014). Review of therapeutic drug monitoring of anticancer drugs part two–targeted therapies. European Journal of Cancer, 50(12), 2020-2036
• [49] Walker, P. A., Ryder, S., Lavado, A., Dilworth, C., & Riley, R. J. (2020). The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development. Archives of Toxicology, 94(8), 2559-2585

• Document Type: article